Ads
related to: biogen alzheimer's drug phase 3- About Leqembi
Learn more about the treatment
option & how it works.
- Leqembi Companion
Your online partner designed to
support you during treatment.
- Support & Resources
View patient support info and
downoadable resources on site.
- Leqembi Care Partner
Explore tips for supporting
patients who are taking Leqembi.
- Getting Started
Find treatment tips to get started
with Leqembi.
- Sign Up For More Info
Get access to information all about
treatment & useful tips.
- About Leqembi
Search results
Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others
Investor's Business Daily· 2 years agoRoche said its experimental Alzheimer's treatment failed in two final-phase tests, leading Biogen...
Experimental Alzheimer’s drug shows benefits in phase 3 trial, company says
TODAY via Yahoo News· 2 years agoThe Japanese drugmaker Eisai said Tuesday its experimental drug for Alzheimer’s disease helped slow...
Biogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm
Zacks via Yahoo Finance· 4 months agoBiogen (BIIB) aims to build a leading Alzheimer's disease franchise with the new drug Leqembi. The...
Biogen soars 43% after its Alzheimer's drug helps slow down cognitive decline in late-stage study
Business Insider via Yahoo Finance· 2 years agoXinhua/Wang Ying/ Getty Images Biogen soared 43% on Wednesday after the company's Alzheimer's drug...
New Alzheimer's drug from Biogen, Eisai gets government approval, but faces long road ahead
Yahoo Finance· 11 months agoA new Alzheimer's drug from Eisai and Biogen (BIIB) is now fully approved by the FDA, opening the...
New Experimental Alzheimer’s Drug, Lecanemab, Shows Positive Results
Prevention via Yahoo News· 2 years agoAlzheimer’s Drug Lecanemab: What You Need to KnowVisoot Uthairam - Getty Images An experimental drug...
FDA grants full approval to new Alzheimer's drug meant to slow disease
NBC News via Yahoo News· 11 months agoThe Food and Drug Administration has approved lecanemab, a drug developed by Eisai and Biogen with...
Biogen Surges On A Setback For Eli Lilly's Rival Alzheimer's Treatment
Investor's Business Daily· 3 months agoBiogen stock jumped Friday after the Food and Drug Administration delayed its approval decision on...
Biogen (BIIB), Eisai's Alzheimer Drug Likely to Get Full FDA Nod
Zacks via Yahoo Finance· 12 months agoBased on briefing documents issued by the FDA, a full regulatory approval is expected on Biogen...
FDA Approves Lecanemab, a New Alzheimer’s Drug
Time via Yahoo News· 1 year agoCredit - Eisai Inc On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages....
Ad
related to: biogen alzheimer's drug phase 3